Basit öğe kaydını göster

Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.

dc.contributor.authorEser, Ozturk
dc.contributor.authorOray, Merih
dc.contributor.authorTUGAL-TUTKUN, I
dc.date.accessioned2021-03-06T11:38:15Z
dc.date.available2021-03-06T11:38:15Z
dc.identifier.citationEser O., Oray M., TUGAL-TUTKUN I., "Tocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.", Ocular immunology and inflammation, cilt.26, ss.1005-1014, 2018
dc.identifier.issn0927-3948
dc.identifier.othervv_1032021
dc.identifier.otherav_effafb85-1d54-433f-93e8-a0a3bb4c0d90
dc.identifier.urihttp://hdl.handle.net/20.500.12627/157506
dc.identifier.urihttps://doi.org/10.1080/09273948.2017.1355471
dc.language.isoeng
dc.titleTocilizumab for the Treatment of Behçet Uveitis that Failed Interferon Alpha and Anti-Tumor Necrosis Factor-Alpha Therapy.
dc.typeMakale
dc.relation.journalOcular immunology and inflammation
dc.contributor.department, ,
dc.identifier.volume26
dc.identifier.startpage1005
dc.identifier.endpage1014
dc.contributor.firstauthorID176776


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster